Lancet neurology
The most recent articles from:
Lancet Neurol
-
Myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Treatment typically includes symptomatic oral cholinesterase inhibitors, immunosuppression, and immunomodulation. In addition to corticosteroids, azathioprine and mycophenolate mofetil are the most frequently used immunosuppressants in North America. We aimed to evaluate the comparative effectiveness of these two drugs, and to assess the effect of the dose and duration of treatment. ⋯ Patient-Centered Outcomes Research Institute, Myasthenia Gravis Foundation of America.